Jelena Dinić

3.9k total citations
65 papers, 1.1k citations indexed

About

Jelena Dinić is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Jelena Dinić has authored 65 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 44 papers in Molecular Biology, 22 papers in Oncology and 8 papers in Cancer Research. Recurrent topics in Jelena Dinić's work include Drug Transport and Resistance Mechanisms (13 papers), Cancer therapeutics and mechanisms (9 papers) and Natural product bioactivities and synthesis (7 papers). Jelena Dinić is often cited by papers focused on Drug Transport and Resistance Mechanisms (13 papers), Cancer therapeutics and mechanisms (9 papers) and Natural product bioactivities and synthesis (7 papers). Jelena Dinić collaborates with scholars based in Serbia, Spain and Italy. Jelena Dinić's co-authors include Milica Pešić, Ingela Parmryd, Ana Podolski-Renić, Tijana Stanković, Jeremy Adler, Jasna Banković, Henrik Biverståhl, Lena Mäler, Astrid Riehl and Saleemulla Mahammad and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Scientific Reports.

In The Last Decade

Jelena Dinić

61 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jelena Dinić Serbia 19 671 219 168 105 86 65 1.1k
Kaori Honda Japan 18 708 1.1× 141 0.6× 149 0.9× 131 1.2× 71 0.8× 47 1.0k
Tingting Liu China 22 974 1.5× 351 1.6× 287 1.7× 97 0.9× 108 1.3× 79 1.6k
Qiu Sun China 18 884 1.3× 261 1.2× 245 1.5× 101 1.0× 54 0.6× 60 1.6k
Jeff Posakony United States 16 658 1.0× 197 0.9× 288 1.7× 59 0.6× 74 0.9× 25 1.5k
Mark Agostino Australia 16 778 1.2× 165 0.8× 153 0.9× 110 1.0× 73 0.8× 41 1.1k
Ana Podolski-Renić Serbia 21 600 0.9× 321 1.5× 279 1.7× 137 1.3× 47 0.5× 55 1.2k
ŞERBAN COMŞA Romania 7 379 0.6× 245 1.1× 110 0.7× 130 1.2× 67 0.8× 13 854
Yongliang Yang China 23 885 1.3× 254 1.2× 122 0.7× 191 1.8× 59 0.7× 64 1.4k
Julie A. Zorn United States 16 947 1.4× 265 1.2× 226 1.3× 63 0.6× 90 1.0× 21 1.5k
Helena Almqvist Sweden 9 902 1.3× 225 1.0× 115 0.7× 88 0.8× 88 1.0× 12 1.3k

Countries citing papers authored by Jelena Dinić

Since Specialization
Citations

This map shows the geographic impact of Jelena Dinić's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jelena Dinić with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jelena Dinić more than expected).

Fields of papers citing papers by Jelena Dinić

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jelena Dinić. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jelena Dinić. The network helps show where Jelena Dinić may publish in the future.

Co-authorship network of co-authors of Jelena Dinić

This figure shows the co-authorship network connecting the top 25 collaborators of Jelena Dinić. A scholar is included among the top collaborators of Jelena Dinić based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jelena Dinić. Jelena Dinić is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Isca, Vera M. S., Jelena Dinić, Milica Pešić, et al.. (2024). Investigating SAR Insights into Royleanones for P-gp Modulation. SHILAP Revista de lepidopterología. 35–35.
3.
Dinić, Jelena, Sofija Jovanović Stojanov, Thomas Mohr, et al.. (2024). Multidrug-Resistant Profiles in Non-Small Cell Lung Carcinoma Patient-Derived Cells: Implications for Personalized Approaches with Tyrosine Kinase Inhibitors. Cancers. 16(11). 1984–1984. 3 indexed citations
4.
Dinić, Jelena, et al.. (2024). Cancer Patient-Derived Cell-Based Models: Applications and Challenges in Functional Precision Medicine. Life. 14(9). 1142–1142. 1 indexed citations
5.
Stojanov, Sofija Jovanović, Adrián Puerta, Jelena Dinić, et al.. (2024). Coumarins-lipophilic cations conjugates: Efficient mitocans targeting carbonic anhydrases. Bioorganic Chemistry. 145. 107168–107168. 6 indexed citations
6.
Puerta, Adrián, Jelena Dinić, Sofija Jovanović Stojanov, et al.. (2023). Biotinylated selenocyanates: Potent and selective cytostatic agents. Bioorganic Chemistry. 133. 106410–106410. 10 indexed citations
7.
Dinić, Jelena, et al.. (2021). Bacterial Nanocellulose as a Scaffold for In Vitro Cell Migration Assay. Nanomaterials. 11(9). 2322–2322. 7 indexed citations
8.
Puerta, Adrián, Jelena Dinić, Milica Pešić, et al.. (2021). Straightforward access to novel mitochondriotropics derived from 2-arylethanol as potent and selective antiproliferative agents. European Journal of Medicinal Chemistry. 228. 113980–113980. 5 indexed citations
9.
Podolski-Renić, Ana, Jelena Dinić, Tijana Stanković, et al.. (2019). Modulation of Antioxidant Potential with Coenzyme Q10 Suppressed Invasion of Temozolomide-Resistant Rat Glioma In Vitro and In Vivo. Oxidative Medicine and Cellular Longevity. 2019. 1–14. 19 indexed citations
10.
Fallacara, Anna Lucia, Claudio Zamperini, Ana Podolski-Renić, et al.. (2019). A New Strategy for Glioblastoma Treatment: In Vitro and In Vivo Preclinical Characterization of Si306, a Pyrazolo[3,4-d]Pyrimidine Dual Src/P-Glycoprotein Inhibitor. Cancers. 11(6). 848–848. 39 indexed citations
11.
Dinić, Jelena, et al.. (2019). Potential of Natural-Based Anticancer Compounds for P-Glycoprotein Inhibition. Current Pharmaceutical Design. 24(36). 4334–4354. 17 indexed citations
12.
Dinić, Jelena, et al.. (2018). Alkylamino and aralkylamino derivatives of avarone and its mimetic as selective agents against non-small cell lung cancer cells, their antibacterial and antifungal potential. Journal of the Serbian Chemical Society. 83(11). 1193–1207. 2 indexed citations
13.
Podolski-Renić, Ana, Szilvia Bősze, Jelena Dinić, et al.. (2017). Ferrocene–cinchona hybrids with triazolyl-chalcone linkers act as pro-oxidants and sensitize human cancer cell lines to paclitaxel. Metallomics. 9(8). 1132–1141. 38 indexed citations
14.
Podolski-Renić, Ana, Jelena Dinić, José M. Ayuso, et al.. (2016). Resistance to DNA Damaging Agents Produced Invasive Phenotype of Rat Glioma Cells—Characterization of a New in Vivo Model. Molecules. 21(7). 843–843. 9 indexed citations
16.
Stanković, Tijana, Jasna Banković, Jelena Dinić, et al.. (2014). Comparative analyses of individual and multiple alterations of p53, PTEN and p16 in non-small cell lung carcinoma, glioma and breast carcinoma samples. Biomedicine & Pharmacotherapy. 68(5). 521–526. 10 indexed citations
17.
Novaković, Miroslav, Milica Pešić, Snežana Trifunović, et al.. (2013). Diarylheptanoids from the bark of black alder inhibit the growth of sensitive and multi-drug resistant non-small cell lung carcinoma cells. Phytochemistry. 97. 46–54. 31 indexed citations
18.
Nikolić, Aleksandra, et al.. (2013). Clinical presentation of mild cystic fibrosis in a Serbian patient homozygous for the CFTR mutation c.1393-1G>A. Journal of Cystic Fibrosis. 13(1). 111–113. 4 indexed citations
19.
Dinić, Jelena, et al.. (2008). MTHFR C677T polymorphism in chronic pancreatitis and pancreatic adenocarcinoma. Cell Biochemistry and Function. 26(6). 659–663. 11 indexed citations
20.
Dinić, Jelena, et al.. (2007). Analysis of Y chromosome microdeletions and CFTR gene mutations as genetic markers of infertility in Serbian men. Vojnosanitetski pregled. 64(4). 253–256. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026